Scarica l'app Stockscreener
13.74
2.00%
0.27
Precedente Chiudi:
$13.47
Aprire:
$13.5
Volume 24 ore:
99,692
Relative Volume:
0.85
Capitalizzazione di mercato:
$601.77M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.31%
1M Prestazione:
-8.70%
6M Prestazione:
+14.69%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.22
$13.85
Intervallo di 1 settimana:
$12.89
$14.58
Portata 52W:
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
Nome
Maze Therapeutics Inc
Settore
Industria
Telefono
(650) 850-5070
Indirizzo
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Confronta MAZE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
13.74 | 589.95M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-08 | Iniziato | Wedbush | Outperform |
Maze Therapeutics Inc Borsa (MAZE) Ultime notizie
Is it time to cut losses on Maze Therapeutics Inc.Free Fast Gaining Stock Screener Report - Newser
Will Maze Therapeutics Inc. stock recover after earningsExploding Volume High ROI Picks - newsyoung.net
Institutional scanner results for Maze Therapeutics Inc.Free Buy Alerts With Low Risk Confirmation - Newser
Maze Therapeutics reports Q2 EPS (77c), consensus ($1.15) - TipRanks
When is the best time to exit Maze Therapeutics Inc.Technical Chart Summary for Momentum Stocks - Newser
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - GlobeNewswire
Published on: 2025-08-12 08:41:52 - Newser
What’s the recovery path for long term holders of Maze Therapeutics Inc.AI Trading Forecast Based on Big Data - Newser
Will a bounce in Maze Therapeutics Inc. offer an exitBuy and Hold Strategy for Capital Safety - Newser
Why Maze Therapeutics Inc. stock attracts strong analyst attentionAI Trade Signal Forecast with Chart Logic - Newser
Using data models to predict Maze Therapeutics Inc. stock movementAI-Based Stock Behavior Forecast Engine - Newser
What moving averages say about Maze Therapeutics Inc.Profit Target Planning with Exit Confidence - Newser
How to build a custom watchlist for Maze Therapeutics Inc.Real Market Tracker with Price Action Tools - Newser
What makes Maze Therapeutics Inc. stock price move sharplyStock Entry Point Planner with Volume Spike - Newser
Visual trend scoring systems applied to Maze Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Real time pattern detection on Maze Therapeutics Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
How Maze Therapeutics Inc. stock performs during market volatilityTrade Setup Builder with Custom Alerts - Newser
Bank of New York Mellon Corp Makes New Investment in Maze Therapeutics, Inc. (NASDAQ:MAZE) - Defense World
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $25.60 Average Price Target from Analysts - Defense World
How does Maze Therapeutics Inc. compare to its industry peersFast-track wealth growth - Jammu Links News
What are the technical indicators suggesting about Maze Therapeutics Inc.Invest confidently with real-time market updates - Jammu Links News
How volatile is Maze Therapeutics Inc. stock compared to the marketDiscover top stock picks for aggressive growth - Jammu Links News
What institutional investors are buying Maze Therapeutics Inc. stockFree Stock Market Forecast Reports - Jammu Links News
What are analysts’ price targets for Maze Therapeutics Inc. in the next 12 monthsInvest confidently with advanced analysis tools - Jammu Links News
What drives Maze Therapeutics Inc. stock priceCapitalize on emerging market opportunities - Jammu Links News
Is Maze Therapeutics Inc. a growth stock or a value stockBuild wealth steadily with proven stock picks - Jammu Links News
Is Maze Therapeutics Inc. stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Is Maze Therapeutics Inc. stock poised for growthFree Alpha Driven Watchlist With Alerts - Newser
Why is Maze Therapeutics Inc. stock attracting strong analyst attentionUnmatched profit potential - Jammu Links News
What are the latest earnings results for Maze Therapeutics Inc.High-profit capital plays - Jammu Links News
What is Maze Therapeutics Inc. company’s growth strategyWealth Building Planner With Proven Results - jammulinksnews.com
How to escape a deep drawdown in Maze Therapeutics Inc.Trade Safety Matrix for Conservative Traders - Newser
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ZimVie Inc (ZIMV) - The Globe and Mail
What to do if you’re stuck in Maze Therapeutics Inc.Quarterly Investment Outlook and Key Summary - Newser
Maze Therapeutics Inc Azioni (MAZE) Dati Finanziari
Non sono disponibili dati finanziari per Maze Therapeutics Inc (MAZE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):